Search Within

Hana Andrlova

Formats
  1. Journal Article (8)
  2. Meeting Abstract (3)
  3. Review (1)
Groups
  1. Center for Hematologic Malignancies (12)
  2. GSK Faculty (12)
  3. Hematologic Malignancies, Division of (12)
  4. Immunology Program Faculty (12)
  5. Sloan Kettering Institute Faculty (12)
  6. Sloan Kettering Institute Postdocs (12)

More Groups

People
  1. Marcel Van Den Brink (11)
  2. Marina Burgos da Silva (8)
  3. Susan Dewolf (8)
  4. Anqi Dai (7)
  5. Jonathan Peled (7)
  6. Anastasia Kousa (6)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (2)
Publications
  1. Blood (4)
  2. Science Translational Medicine (2)
  3. Frontiers in Oncology (1)
  4. Immunity (1)
  5. Nature Communications (1)
  6. Nature Immunology (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Nature Publishing Group (3)
  3. American Association for the Advancement of Science (2)
  4. Cell Press (1)
  5. Frontiers Media S.A. (1)
  6. Wiley Periodicals, Inc (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MAIT and Vδ2 unconventional T cells predict favorable outcome after allogeneic HCT and are supported by a diverse intestinal microbiome
    Meeting Abstract

    Andrlova, H.; Miltiadous, O.; Dai, A.; Gardner, R.; El Daker, S.; Slingerland, J. B.; Giardina, P. A.; Clurman, A.; Gomes, A. L. C.; Nguyen, C. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • An unconventional view of T cell reconstitution after allogeneic hematopoietic cell transplantation
    Review

    Andrlová, H.; van den Brink, M. R. M.; Markey, K. A.
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save